Right To Try Debate Highlights Specialty Pharmacy Week in Review

Jul 3, 2016

By Davy James, Managing Editor

Top articles of the week on Specialty Pharmacy Times.

[<a href="//storify.com/pharmacytimes/right-to-try-debate-highlights-specialty-pharmacy-" target="_blank">View the story "Right To Try Debate Highlights Specialty Pharmacy Week in Review" on Storify</a>]

Related Videos

Related Content

MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer

January 27th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer

January 27th 2023

Study Results Show Link Between Moderate or Vigorous Physical Activity and Brain Power

January 27th 2023

MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer

January 27th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer

January 27th 2023

Study Results Show Link Between Moderate or Vigorous Physical Activity and Brain Power

January 27th 2023

MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer

January 27th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer

January 27th 2023

Study Results Show Link Between Moderate or Vigorous Physical Activity and Brain Power

January 27th 2023

Related Content

MIS Biomarker May Effectively Anticipate Outcome of Immune Checkpoint Inhibitors for Colorectal Cancer

January 27th 2023

Pharmacy Focus: Student Edition - Career in PBMs

January 23rd 2023

Panel: Collaboration, Increased Naloxone Availability Can Help Prevent Opioid-Related Deaths

January 27th 2023

BONUS: Public Health Matters - Highlighting Women of Color in Pharmacy

January 19th 2023

FDA Approves Adjuvant Pembrolizumab for Non–Small Cell Lung Cancer

January 27th 2023

Study Results Show Link Between Moderate or Vigorous Physical Activity and Brain Power

January 27th 2023

Recent Content

View More Recent Content

Editorial Staff

Terms & Conditions

Do Not Sell My Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.